1994
DOI: 10.1016/0020-7292(94)90059-0
|View full text |Cite
|
Sign up to set email alerts
|

Breast cancer in mothers prescribed diethylstilbestrol in pregnancy: Further follow-up

Abstract: Objective.\p=m-\Further assessment of the long-term risk of breast cancer associated with diethylstilbestrol (DES) during pregnancy.Design.\p=m-\Follow-up continuation through June 1, 1989, of a historical cohort of DES-exposed and unexposed mothers ascertained by review of obstetric records.Participants. METHODSThe original report of this study con¬ tained a detailed description of study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
14
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 0 publications
0
14
0
Order By: Relevance
“…No clear relationship between adverse general health effects and exposure to endocrine modulators has been established, although involvement of EDs in human pathology has been suggested in numerous studies (95)(96)(97)(98)(99)(100)(101)(102). The influence of chemical compounds on allergic immune responses remains also unclear.…”
Section: Resultsmentioning
confidence: 99%
“…No clear relationship between adverse general health effects and exposure to endocrine modulators has been established, although involvement of EDs in human pathology has been suggested in numerous studies (95)(96)(97)(98)(99)(100)(101)(102). The influence of chemical compounds on allergic immune responses remains also unclear.…”
Section: Resultsmentioning
confidence: 99%
“…One of the clearest examples involves diethylstilbestrol (DES). While adult exposure to diethylstilbestrol (DES) modestly increases the risk of breast cancer and mortality from this disease later in life (RR = 1.27-1.35 for risk of disease and mortality with DES exposure) [19][20][21], fetal exposure to this agent apparently increases the incidence breast cancer in adult women much more dramatically (RR = 3.0 after the age of 50 yr) [22]. Similarly, clear cell adenocarcinomas of the vagina, a very rare cancer, has been observed in patients exposed prenatally to DES, but not after adult exposure [19;23;24].…”
Section: Assessment Of Bisphenol A-induced Carcinogenicity In Adult Rmentioning
confidence: 99%
“…Additional information will become available as more women with long-term oral contraceptive use reach the ages of higher breast cancer risk. Diethystilbestrol (DES), a potent synthetic estrogen, has been linked to increased breast cancer risk in women who took DES during pregnancy (Colton et al 1993;Titus-Ernstoff et al 2001).…”
Section: Introductionmentioning
confidence: 99%